ZyVersa Therapeutics (ZVSA) Stock Chart & Stock Price History $0.16 +0.01 (+6.67%) As of 12:06 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZyVersa Therapeutics Stock Price Performance The ZyVersa Therapeutics (ZVSA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.19%, with a year-to-date return of -84.91%. In the past month, the stock has decreased 2.68%, reflecting recent market activity. As of the latest close, ZyVersa Therapeutics traded at $0.15 with a market cap of $1.19 million and volume of 34,029 shares. Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.06%1 Month Performance-2.68%3 Month Performance-72.88%Year-To-Date Performance-84.91%1 Year Performance-93.19% ZVSA Stock Chart for Friday, October, 10, 2025 ZVSA Chart by TradingView ZyVersa Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/09/2025$0.14$0.15+5.12%$0.17$0.1434,029 shs$1.19 million10/08/2025$0.17$0.14-13.98%$0.18$0.1460,810 shs$1.13 million10/07/2025$0.16$0.17+3.69%$0.18$0.1424,783 shs$1.32 million10/06/2025$0.16$0.16-0.06%$0.18$0.1533,952 shs$1.27 million10/03/2025$0.16$0.16+0.13%$0.18$0.1338,866 shs$1.27 million10/02/2025$0.14$0.16+11.82%$0.16$0.1341,779 shs$1.27 million10/01/2025$0.15$0.14-2.72%$0.16$0.1322,924 shs$1.14 million09/30/2025$0.15$0.15+1.38%$0.15$0.1351,911 shs$1.17 million09/29/2025$0.15$0.15-1.83%$0.15$0.1432,371 shs$1.15 million09/26/2025$0.18$0.15-17.25%$0.17$0.1524,891 shs$1.17 million Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/25/2025$0.17$0.18+5.00%$0.18$0.1753,502 shs$1.42 million09/24/2025$0.16$0.17+4.62%$0.18$0.1611,035 shs$1.35 million09/23/2025$0.16$0.16+1.56%$0.18$0.1619,988 shs$1.29 million09/22/2025$0.15$0.16+6.67%$0.18$0.1547,643 shs$1.27 million09/19/2025$0.16$0.15-6.25%$0.18$0.1514,121 shs$1.19 million09/18/2025$0.17$0.16-3.03%$0.18$0.1513,193 shs$1.27 million09/17/2025$0.18$0.17-7.51%$0.18$0.1373,708 shs$1.31 million09/16/2025$0.18$0.18-0.06%$0.18$0.1422,381 shs$1.42 million09/15/2025$0.15$0.18+16.59%$0.18$0.15129,319 shs$1.42 million09/12/2025$0.16$0.15-4.31%$0.16$0.1561,051 shs$1.22 million09/11/2025$0.16$0.16-2.68%$0.18$0.1431,953 shs$1.27 million09/10/2025$0.14$0.16+17.43%$0.16$0.1328,094 shs$1.31 million09/09/2025$0.15$0.14-7.47%$0.15$0.1433,896 shs$1.11 million Related Companies BDRX Stock Price Chart SHPH Stock Price Chart ADTX Stock Price Chart TRIB Stock Price Chart DRMA Stock Price Chart REVB Stock Price Chart SPRC Stock Price Chart ARTL Stock Price Chart INDP Stock Price Chart ARAV Stock Price Chart Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVSA) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.For the everyday American who's worked hard to build their nest egg, Trump preserved a IRS loophole that allow...American Hartford Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
